Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Normal immunoglobulin human 5g/50ml inf bottles
1405010A0AABKBK
|
Normal immunoglobulin human | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Normal immunoglobulin human 5g/50ml inf vials
1405010A0AABPBP
|
Normal immunoglobulin human | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Normal immunoglobulin human 6g inf bottles
1405010A0AAAIAI
|
Normal immunoglobulin human | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Normal immunoglobulin human 6g/50ml inf vials
1405010A0AABHBH
|
Normal immunoglobulin human | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Normal immunoglobulin human 750mg/4.6875ml inj vials
1405010A0AAAEAE
|
Normal immunoglobulin human | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Normal immunoglobulin human 800mg/5ml inj vials
1405010A0AABEBE
|
Normal immunoglobulin human | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Normal immunoglobulin human 8g/40ml inf vials
1405010A0AACRCR
|
Normal immunoglobulin human | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Normal immunoglobulin human 8g/48ml inj vials
1405010A0AACPCP
|
Normal immunoglobulin human | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.